We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInter. Pers. Regulatory News (IPF)

Share Price Information for Inter. Pers. (IPF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 104.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.50 (1.449%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 104.00
IPF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Final Confirmation & Results of Exchange Offer

7 Jun 2019 17:01

RNS Number : 5869B
International Personal Finance Plc
07 June 2019
 

The information contained herein may only be released, published or distributed in the United Kingdom, the Isle of Man, Jersey and the Bailiwick of Guernsey in accordance with applicable regulatory requirements. The information contained herein is not for release, publication or distribution in or into the United States, Australia, Canada, Japan, South Africa, the Republic of Ireland or in any other jurisdiction where it is unlawful to distribute this document.

THIS ANNOUNCEMENT RELATES TO THE DISCLOSURE OF INFORMATION THAT QUALIFIED OR MAY HAVE QUALIFIED AS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(10) OF THE MARKET ABUSE REGULATION (EU) 596/2014.

SEE "IMPORTANT INFORMATION" BELOW

 

 

INTERNATIONAL PERSONAL FINANCE PLC (THE "ISSUER")

 

7 June 2019

 

Final Terms Confirmation and Results of Exchange Offer Announcement

 

This announcement constitutes the Final Terms Confirmation Announcement referred to in (i) the Final Terms dated 16 May 2019 relating to the proposed issue by the Issuer of 7.75 per cent. notes due 2023 for cash (the "Additional Notes Final Terms"); and (ii) the Final Terms contained in pages 58 to 69 of the Exchange Offer Memorandum dated 16 May 2019 (the "Exchange New Notes Final Terms" and the "Exchange Offer Memorandum") relating to the proposed offer for exchange of the Issuer's outstanding sterling denominated 6.125% bonds due 2020 (ISIN: XS0919406800) (the "Existing 2020 Notes") for 7.75 per cent. notes due 2023.

This announcement also hereby announces the results of the Exchange Offer referred to in the Exchange Offer Memorandum. This announcement must be read in conjunction with, and as applicable, the Prospectus, the Supplementary Prospectus, the Exchange Offer Memorandum (including the Exchange New Notes Final Terms) and the Additional Notes Final Terms (in all cases as defined above or below).

The Prospectus, the Supplementary Prospectus, the Exchange Offer Memorandum (including the Exchange New Notes Final Terms) and the Additional Notes Final Terms are available for viewing on the website of Lucid Issuer Services Limited (https://portal.lucid-is.com).

The Exchange Period relating to the Exchange Offer and the Offer Period relating to the offer of Additional Notes expired at 12 Noon on 7 June 2019 and accordingly the Exchange New Notes and the Additional Notes (together, the "Notes") can no longer be subscribed for nor be obtained by way of application for exchange. Accordingly, this announcement is not an offer to subscribe, tender, sell or exchange any securities.

Unless otherwise defined herein, terms used herein shall, as applicable, have the meaning given to them in the base prospectus published on 12 April 2019 (the "Prospectus") as supplemented by a supplementary prospectus published on 7 May 2019 (the "Supplementary Prospectus"), the Exchange Offer Memorandum and the Additional Notes Final Terms.

The Exchange New Notes and the Additional Notes to be issued will be consolidated and form a single series on the Issue Date, with ISIN XS1998163148.

The Issuer confirms the following for the purposes of this Final Terms Confirmation Announcement:

Aggregate Nominal Amount of the Series of Notes to be issued:

£78,100,000

Estimated net proceeds of the offer of the Series of Notes to be issued:

£19,492,300 (being the Aggregate Nominal Amount of the Notes issued pursuant to the Cash Offer at the Issue Price of 100% less the fees payable to the Dealer Managers in respect of both the issuance of the Additional Notes and the Exchange New Notes; and

£57,401,900 in the form of the aggregate nominal amount of Existing 2020 Notes accepted for exchange pursuant to the Exchange Offer.

Estimated expenses relating to the offer of the Series of Notes to be issued:

£1,205,800 (being the fees payable to the Dealer Managers in relation to both the Exchange New Notes and the Additional New Notes and deducted as described in estimated net proceeds of the offer of the Series of Notes to be issued above).

In relation to the Exchange Offer, the aggregate nominal amount of Existing 2020 Notes accepted for exchange by the Issuer is £57,401,900. Accordingly, the aggregate nominal amount of Existing 2020 Notes outstanding after the Exchange Offer will be £44,098,100.

 

-Ends-

 

For further information, please see IPF's website at http://www.ipfin.co.uk or contact:

 

James Ormrod (Chief Legal Officer)

+44 (0) 113 285 6824

Rachel Moran (Investor Relations Manager)

+44 (0) 113 285 6798

Nick Dahlgreen (Group Treasurer)

+44 (0) 113 285 6921

IMPORTANT INFORMATION

This announcement is released by International Personal Finance plc and contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR), encompassing information relating to an offer of securities, as described above. For the purposes of MAR and Article 2 of Commission Implementing Regulation (EU) 2016/1055, this announcement is made by James Ormrod, Chief Legal Officer for International Personal Finance plc.

The offering and the distribution of this announcement and other information in connection with any offer in certain jurisdictions may be restricted by law and persons into whose possession this announcement or any document or other information referred to herein comes should inform themselves about and observe any such restriction. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdiction.

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase. Any purchase of Notes pursuant to any offer should only be made on the basis of (as applicable) the information contained in the Base Prospectus, the Supplementary Prospectus, the Exchange Offer Memorandum, the Additional Notes Final Terms and the Exchange New Notes Final Terms referred to above. The Base Prospectus, the Supplementary Prospectus, the Exchange Offer Memorandum, the Additional Notes Final Terms and the Exchange New Notes Final Terms are available for viewing at (https://portal.lucid-is.com).

The Notes have not been and will not be registered under the US Securities Act of 1933, as amended, (the "Securities Act") and, subject to certain exceptions, may not be offered, sold or delivered within the United States or to, or for the account or benefit of U.S. persons (as defined in the Securities Act). The Notes are being offered and sold outside of the United States in reliance on Regulation S of the Securities Act. There will be no public offering in the United States.

Legal Entity Identifier: 213800II1O44IRKUZB59

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCLLFEERRIDIIA
Date   Source Headline
8th Apr 20241:13 pmRNSDirector/PDMR Shareholding
5th Apr 202410:00 amRNSDirector/PDMR Shareholding
4th Apr 202410:48 amRNSDirector/PDMR Shareholding
3rd Apr 20243:29 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
27th Mar 20245:09 pmRNSDirector/PDMR Shareholding
25th Mar 20244:44 pmRNSAnnual Financial Report and Notice of AGM
21st Mar 20245:09 pmRNSDirector/PDMR Shareholding
19th Mar 20243:56 pmRNSDirector/PDMR Shareholding
18th Mar 20244:11 pmRNSDirector/PDMR Shareholding
15th Mar 202410:38 amRNSFinal Dividend Timetable Correction
14th Mar 20247:00 amRNSFinal Results and Accounts
26th Feb 20247:00 amRNSDelay of year-end results announcement
8th Feb 20247:00 amRNSDirector/PDMR Shareholding
27th Dec 20239:08 amRNSHolding(s) in Company
14th Dec 202311:24 amRNSPublication of Final Terms
24th Nov 20237:02 amRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSFinal Confirmation & Results of Exchange Offer
17th Nov 20233:18 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSAppointment of Joint Broker
14th Nov 20233:09 pmRNSHolding(s) in Company
8th Nov 20237:00 amRNSNotice of Investor Webinar - 7 December 2023
3rd Nov 20234:14 pmRNSIssuance and amendment to Final Terms
2nd Nov 20231:29 pmRNSCash Offer Launch
2nd Nov 20231:18 pmRNSExchange Offer
2nd Nov 20231:16 pmRNSPublication of a Prospectus
26th Oct 20237:01 amRNSRoadshow Announcement
26th Oct 20237:00 amRNSQ3 2023 Trading Update
25th Oct 20232:12 pmRNSChange of Senior Independent Director
24th Oct 20233:19 pmRNSPublication of Final Terms - Replacement Notice
24th Oct 20237:00 amRNSPublication of Final Terms
20th Oct 20237:00 amRNSUpdate on Annual General Meeting 2023 Vote
2nd Oct 20237:00 amRNSTotal Voting Rights
14th Sep 20231:46 pmRNSDirector/PDMR Shareholding
1st Sep 20237:00 amRNSTotal Voting Rights
24th Aug 20234:35 pmRNSPublication of a Prospectus
1st Aug 20237:00 amRNSHalf-year Report
13th Jul 202311:14 amRNSHolding(s) in Company
3rd Jul 20232:30 pmRNSTotal Voting Rights
3rd Jul 20239:20 amRNSBlock listing Interim Review
1st Jun 20237:00 amRNSTotal Voting Rights
11th May 20234:48 pmRNSDirector/PDMR Shareholding
4th May 202311:17 amRNSDirector/PDMR Shareholding
2nd May 202312:28 pmRNSTotal Voting Rights
27th Apr 20234:27 pmRNSResult of AGM
27th Apr 20237:00 amRNSQ1 2023 Trading Update
19th Apr 20234:44 pmRNSNotice of Investor Briefing - 10 May 2023
6th Apr 20232:54 pmRNSDirector/PDMR Shareholding
4th Apr 20234:42 pmRNSDirector/PDMR Shareholding
3rd Apr 20233:37 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.